I+D de fármacos
GI-1606
Karolinska Institute
Estocolmo, SueciaPublikationen in Zusammenarbeit mit Forschern von Karolinska Institute (1)
2012
-
A new mechanism of action for the anticancer drug Mitomycin C: Mechanism-based inhibition of thioredoxin reductase
Chemical Research in Toxicology, Vol. 25, Núm. 7, pp. 1502-1511